SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Pharmos(PARS) -- Ignore unavailable to you. Want to Upgrade?


To: Richard Huth who wrote (1347)10/7/1998 3:05:00 PM
From: NeuroInvestment  Read Replies (1) | Respond to of 1491
 
The negative action in the stock price does not represent a valid marker of the trial's success--it was in fact a successful trial, but without the clearcut, dramatic mortality differential that would been an easy read for the general audience. For those who are interested, a more verbose comment is posted on the NI web page, at the following link. NeuroInvestment
neuroinv.com